Evidence map›Paper›PMID 40294162›Full record

ArticleGenetics2025

Proximity labeling identification of plasma membrane eisosome proteins in Candida albicans.

Carla E Lanze, John D Haley, James B Konopka

Abstract read
In one paragraph

Article in Genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Carla E LanzeDepartment of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.ORCID 0000-0002-1662-7065
John D HaleyDepartment of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.ORCID 0000-0002-0283-6413
James B KonopkaDepartment of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.ORCID 0000-0001-5989-4086

Funding

Regulation of Morphogenesis in C. albicansR01AI047837 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI James B Konopka · 2001 to 2026
$8.8M
MOLECULAR AND CELL BIOLOGY OF INFECTIOUS DISEASEST32AI007539 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI KONOPKA, JAMES B · 1998 to 2023
$3.6M
C. albicans invasive growthR01AI177553 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI James B Konopka · 2024 to 2026
$2.0M
NIAID NIH HHS R01 AI047837NIAID NIH HHS R01 AI177553NIAID NIH HHS T32 AI007539NIH HHS R01AI047837NIH HHS R01AI177553Public Health Service
6 · The paper itself

Abstract

The ability of Candida albicans to resist stressful conditions in the host and grow invasively into tissues contributes to the virulence of this human fungal pathogen. Plasma membrane subdomains known as the MCC (membrane compartment of Can1) or eisosomes are important for these processes. MCC/eisosome domains are furrow-shaped invaginations of the plasma membrane that are about 250 nm long and 50 nm deep. To identify proteins that localize to these domains, a proximity labeling method was used in which the TurboID variant of the BirA biotin ligase was fused to Sur7 and Lsp1, 2 proteins that localize to eisosomes and are important for virulence. This resulted in biotinylation of nearby proteins, permitting their identification. Analysis of 19 candidate proteins by tagging with the green fluorescent protein identified 7 proteins that detectably overlapped with MCC/eisosomes. Deletion mutant analysis showed that one of these, a poorly studied protein known as Ker1, was important for hyphal growth in liquid culture, invasive growth into agar medium, and resistance to stress caused by copper and cell wall perturbing agents. Altogether, these approaches identified novel MCC/eisosome proteins and show that TurboID can be applied to better define the molecular mechanisms of C. albicans pathogenesis and aid in discovery of targets for novel therapeutic strategies.

Indexed as

Candida albicansCell MembraneFungal ProteinsMembrane ProteinsCell WallVirulenceFungal ProteinsMembrane Proteinscell walleisosomefungifurrowinvasive growthMCC (membrane compartment of Can1)membrane curvaturemorphogenesisstress resistancetetraspan protein

Identifiers

PMID40294162
PMCPMC12135193

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.